Skip to main content
Tech.euFundingExplorerBeta

RetInSight

Exited

Our Artificial Intelligence solutions provide superior diagnostic and therapeutic care for millions of individuals at risk of experiencing retinal diseases - a leading cause of severe vision loss and blindness.

Total raised
€0
€0
Funding rounds
0
Investors
0
distinct backers
Active since

Funding rounds

0 rounds
No funding rounds recorded.

Exit

Type
acquisition
Date
May 2025
Value
Acquiror
Topcon Healthcare (United States of America)

Similar companies

same sector or country